Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study.

MLA

Benn, Marianne, et al. “Low LDL Cholesterol, PCSK9 and HMGCR Genetic Variation, and Risk of Alzheimer’s Disease and Parkinson’s Disease: Mendelian Randomisation Study.” BMJ: British Medical Journal, vol. 357, no. 8103, Apr. 2017, pp. j1648-11. EBSCOhost, https://doi.org/10.1136/bmj.j1648.

APA

Benn, M., Nordestgaard, B. G., Frikke-Schmidt, R., & Tybjærg-Hansen, A. (2017). Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study. BMJ: British Medical Journal, 357(8103), j1648-11. https://doi.org/10.1136/bmj.j1648

Chicago

Benn, Marianne, Børge G. Nordestgaard, Ruth Frikke-Schmidt, and Anne Tybjærg-Hansen. 2017. “Low LDL Cholesterol, PCSK9 and HMGCR Genetic Variation, and Risk of Alzheimer’s Disease and Parkinson’s Disease: Mendelian Randomisation Study.” BMJ: British Medical Journal 357 (8103): j1648-11. doi:10.1136/bmj.j1648.